Target intelligence / Profile preview

Porphyromonas gingivalis outer membrane vesicles (Pg-OMVs)

Target
Pg-OMVs
Molecular classification
Other
01

Overview

Porphyromonas gingivalis outer membrane vesicles (Pg-OMVs) are specialized, spherical nanostructures (50–250 nm) secreted by the Gram-negative keystone pathogen Porphyromonas gingivalis. They serve as concentrated delivery vehicles for a broad spectrum of virulence factors, including proteolytic enzymes (gingipains), lipopolysaccharides (LPS), fimbriae, and small RNAs (msRNAs), allowing these factors to disseminate systemically and access tissues inaccessible to the parent bacteria. Pg-OMVs play a fundamental role in the pathogenesis of chronic periodontitis by modulating host immune responses, inducing tissue destruction, and promoting biofilm stability. Beyond the oral cavity, they are implicated in systemic conditions such as Alzheimer's disease, where they can cross the blood-brain barrier to trigger neuroinflammation and proteinopathy, and cardiovascular disease via the promotion of atherosclerosis. Therapeutic interventions targeting Pg-OMVs primarily involve small-molecule inhibitors that neutralize the activity of encapsulated gingipains or disrupt the biogenesis and adherence of the vesicles to host cells.

Other names
P. gingivalis outer membrane vesiclesPg-OMVsPorphyromonas gingivalis OMVsP.g-OMVsBacterial extracellular vesicles (bEVs) of P. gingivalis
02

Biological functions

Immune responseInterspecies communicationBiofilm formationNutrient acquisitionHost cell invasionCell deathApoptosisHorizontal gene transfer
03

Disease associations

InfectionInflammationNeurodegenerative diseaseCardiovascular diseaseCancerDiabetes mellitusRheumatoid arthritis
04

Safety considerations

Microbiome dysbiosisBlood-brain barrier permeability challengesSystemic inflammatory responsePotential cross-reactivity with human proteases
05

Interacting drugs

Atuzaginstat (COR388)

5 more in the full profile.

06

Biomarkers

Gingipain concentration (Kgp/Rgp) in CSF or salivaP. gingivalis DNA (Pg-DNA)OMV-associated small RNAs (msRNAs)Lipoprotein PG1881Anti-Pg-OMV antibodies

Beyond the preview

Go deeper on Porphyromonas gingivalis outer membrane vesicles (Pg-OMVs).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Porphyromonas gingivalis outer membrane vesicles (Pg-OMVs).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call